CuraTeQ Biologics

CuraTeQ Biologics is an EU GMP certified biopharmaceutical company. We have a pipeline of 14 biosimilars:

• Bevqolva (Bevacizumab) received MHRA approval
• Zefylti (Filgrastim) & Dyrupeg (Pegfilgrastim) received EC & MHRA approvals
• Dazublys (Trastuzumab) received EC, MHRA, & CDSCO approvals

Auro Peptides, our synthetic peptide API manufacturing arm, has filed 14 US DMFs contributing to 6 ANDA approvals. We also offer CMO services in biologics & peptides.